| 英文别名 |
PD-1/PD-L1-IN-8;INCB086550;T8B91S15VF;GTPL11528;BDBM395411;US10308644, Example 24;NSC836941;(3R)-1-[[7-cyano-2-[3-[3-[[3-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]-1,7-naphthyridin-8-yl]amino]-2-methylphenyl]-2-methylphenyl]-1,3-benzoxazol-5-yl]methyl]pyrrolidine-3-carboxylic acid;(R)-1-((7-cyano-2-(3'-(3-(((R)-3-hydroxypyrrolidin-1-yl)methyl)-1,7-naphthyridin-8-ylamino)-2,2'-dimethylbiphenyl-3-yl)benzo[d]oxazol-5-yl)methyl)pyrr;Unii-T8B91S15VF;(R)-1-((7-Cyano-2-(3'-((3-(((R)-3-hydroxypyrrolidin-1-yl)methyl)-1,7-naphthyridin-8-yl)amino)-2,2'-dimethyl-[1,1'-biphenyl]-3-yl)benzo[d]oxazol-5-yl)methyl)pyrrolidine-3-carboxylic acid;INCB 086550;INCB 086550 [WHO-DD];SCHEMBL20294327;(3R)-1-((7-cyano-2-(3-(3-((3-(((3R)-3-hydroxypyrrolidin-1-yl)methyl)-1,7-naphthyridin-8-yl)amino)-2-methylphenyl)-2-methylphenyl)-1,3-benzoxazol-5-yl)methyl)pyrrolidine-3-carboxylic acid;INCB 86550;INCB-086550 [WHO-DD];HY-134884;PD-1 Ligand 1 Inhibitor INCB086550;MS-31148;2378608-10-5;UNII-T8B91S15VF;AKOS040755509;INCB-086550;3-Pyrrolidinecarboxylic acid, 1-[[7-cyano-2-[3'-[[3-[[(3R)-3-hydroxy-1-pyrrolidinyl]methyl]-1,7-naphthyridin-8-yl]amino]-2,2'-dimethyl[1,1'-biphenyl]-3-yl]-5-benzoxazolyl]methyl]-, (3R)-;2230911-59-6;INCB086550(INCB-086550)?;(R)-1-((7-cyano-2-(3'-(3-(((R)-3-hydroxypyrrolidin-1-yl)methyl)-1,7-naphthyridin-8-ylamino)-2,2'-dimethylbiphenyl-3-yl)benzo[d]oxazol-5-yl)methyl)pyrrolidine-3-carboxylic acid;G18291;INCB-86550;PD-L1 Inhibitor INCB086550;EX-A5004;NSC-836941;CS-0160196;3-Pyrrolidinecarboxylic acid, 1-((7-cyano-2-(3'-((3-(((3R)-3-hydroxy-1-pyrrolidinyl)methyl)-1,7-naphthyridin-8-yl)amino)-2,2'-dimethyl(1,1'-biphenyl)-3-yl)-5-benzoxazolyl)methyl)-, (3R)- |
在线客服
专业包装 品类齐全
厂家直发 快捷到货
品牌正品 质量保证
自助下单 尝选无忧
